For future access to innovative technologies/
novel therapeutic drug targets and collaboration
with early stage startup companies
- Ono Venture Investment invests in Immunitas Therapeutics.
(Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases)
- Ono Venture Investment invests in Curreio.
(Curreio Raises JPY310M Series A to advance Cryogenic Electron Microscopy Technology)
- Ono Venture Investment invests in Mediar Therapeutics.
(Mediar Therapeutics Adds New Investors As It Advances Anti-Fibrotic Treatments)